Colorectal carcinomas (CRC) with P53 mutations have been shown to be 2 resistant to chemotherapy with 5-fluorouracil (5-FU), the most widely used 3 chemotherapeutic drug for CRC treatment. Autophagy is emerging as a promising 4 therapeutic target for drug resistant tumors. In the present study, we tested the effects of 5 ursolic acid (UA), a natural triterpenoid, on cell death mechanisms and its effects in 6 combination with 5-FU in the HCT15 p53 mutant apoptosis resistant CRC cell line. The 7 involvement of UA in autophagy and its in vivo efficacy were evaluated. 8
Introduction 22
Colorectal carcinoma (CRC) is the second leading cause of cancer related death 23 and 5-fluorouracil (5-FU) is the main chemotherapeutic agent used in the treatment of 24 this disease [1] . However, significant resistance to 5-FU has been reported and other 25 compounds are needed in order to increase treatment efficacy [2] . Resistance to (with reduced induction of apoptosis) has been associated with tumour cells that 27 harbour P53 mutations [3] [4] [5] . Tumors presenting microsatellite instability (MSI) status, 28 which accounts for 15% of sporadic CRC, have also demonstrated in vitro resistance to 29 5-FU [6] [7] [8] , suggesting little or no benefit from 5-FU treatment in MSI patients, 30 although clinical evidence is not always consistent [8] . These patients, in particular 31 those with MSI and p53 mutations, would clearly gain from new treatment modalities 32 for enhanced efficacy. 33 Apoptotic cell death is a fundamental cellular process that plays an important 34 role during development and tissue homeostasis and has also a profound effect on 35 cancer progression and response to treatment [9] . Apoptosis can be mediated by death 36 receptors (extrinsic pathway) or by the mitochondrial pathway (intrinsic pathway), both 37 involving the activation of caspases [9, 10] . Other alternative cell death mechanisms 38 independent of caspases have been proposed, such as modulation of autophagy [11] . 39 Autophagy is considered a mechanism of cell survival with an important role in 40 preventing early phases of tumor development [12] . However, at late stages of tumor 41 development it may confer anticancer drug resistance [13, 14] . Thus, inhibition of 42 autophagy in resistant cancer cells can lead to cell death and it is currently considered 43 an alternative therapeutic approach [13] . 44 The c-Jun N-terminal kinase (JNK), a stress-activated protein kinase of the 45 family of the mitogen activated protein kinase (MAPK), has been implicated in many 46 In a previous study, UA at 4µM was shown to decrease significantly cell 178 proliferation (by 50%), to inhibit PI3K/Akt pathway and to induce apoptosis as assessed 179 by TUNEL assay [26] . In the present study we aimed to clarify the mechanisms 180 involved in the cell death induced by UA that is only partly due to apoptosis induction. 181
As shown in We had also shown previously that HCT15 cells are resistant to induction of cell 192 death by apoptosis by a common CRC chemotherapeutic drug 5-FU, probably due to 193 the p53 mutation and MSI status [28] . However, when we subjected HCT15 cells to the 194 combination of UA with 5-FU for 48h, at concentrations that were previously shown to 195 decrease cell growth by 50% [26, 28] , a significant enhancement of apoptosis was 196 10 observed when compared with both compounds alone ( MAPK/ERK pathway in HCT15 cells [26] . Here we studied the involvement of the 208 stress kinases p38 and JNK on apoptosis induced by UA in HCT15 cells. Using western 209 blot analysis, we observed that UA significantly induced phospho-JNK (active form) 210 expression (Fig. 2B ). An increase of phospho-JNK expression was also observed for 211 STS and no effect was detected for 5-FU. UA did not change the expression of 212 phospho-p38 expression in HCT15 cells (data not shown). 213
To assess whether apoptosis induction by UA and UA plus FU were dependent 214 on JNK activation, incubations in the presence of 20µM SP600125 (SP), a JNK 215 inhibitor, were performed. As shown in percentage of cell death. Cell death was, therefore, subsequently measured using PI 228 staining, at 2h and 48h. As shown in Supplementary Fig. 3 , UA produced a small 229 increase in cell death after 2h of incubation, indicating no acute necrotic effect. 230
However, after 48h, UA induced cell death in around 50% of cells, as shown by the 231 increase number of PI positive cells (Fig. 3A, Supplementary Fig. 3 ). On the other hand, 232 5-FU alone did not induce significant PI positive cell death and no cumulative effect 233 with UA was observed (Fig. 3A) . These results indicate that UA induces cell death in 234 HCT15 cells more efficiently than 5-FU and also by mechanisms other than apoptosis. 235
We also tested whether JNK pathway was involved in the total cell death induced by 236 UA. As shown in Figure 3A , SP partially inhibited total cell death induced by UA, as 237 well as, the cell death induced by the combination of UA with 5-FU. These data suggest 238 a dependence on JNK signaling also for the total cell death induced by UA in HCT15 239
cells. 240
Recently, autophagy has been argued to be a potential target for induction of cell 241 death in chemoresistant cancer cells [13] . Therefore, we further investigated the 242 possible role of UA in autophagy and the involvement of JNK in this process. As shown 243
in Fig. 3B , UA induced an accumulation of both LC3-II (and to a lower extent also 244 LC3-I) and p62 levels in HCT15 cells after 48h of treatment, which were remarkably 245 prevented in the presence of SP, indicating a role of JNK activation in the accumulation 246 of these autophagic mediators. No effect on LC3-II protein expression was detected in 247 cells treated with 5-FU or SP alone (Fig. 3B) . The LC3-II accumulated in cells treated 248 with UA plus 5-FU seems to be due to UA alone, an effect also inhibited in the presence 249 of SP. The possible role of UA in some upstream regulators of autophagy, such as p53 250 and mTOR, was also investigated. Figure 3B shows that UA decreased both p53 and 251 phospho-mTOR levels, as well as, the levels of p53 induced by 5-FU. These effects are 252 consistent with the potential of UA to modulate autophagy. 253
Interestingly, UA also modulates the same autophagic mediators in other CRC 254 cells, such as the MSI CO115 p53 wild-type cell line ( Supplementary Fig. 4D ). 255
Although in this cell line UA induced apoptosis dependent of caspases, total cell death 256 is higher ( Supplementary Fig. 4A-C analysis of these tumors, a tendency for a higher expression of p62 and phospho-JNK in 267 UA group was observed as compared to controls (Fig. 4B, 4C) . Colocalization of p62 268 and phospho-JNK was, however, only partial. No differences were observed on the 269 tumor expression of LC3 or the proliferation marker Ki67 between treatments ( efficacy, such as loss of p53 transactivation function [3] [4] [5] . Defects in apoptosis play a 276 central role in tumorigenesis and confer resistance to anticancer therapies [29] . 277
Alternative strategies such as autophagy inhibition have been demonstrated to sensitize 278 tumor cells to anticancer drugs [13, 14] . In a previous study, we showed that UA 279 induces apoptosis in HCT15 mutant p53 MSI human CRC cell line [26] . This cell line is 280 also resistant to 5-FU [28] , and here we showed that combination of this 281 chemotherapeutic agent with UA significantly enhanced apoptosis as compared with 5-282 FU alone. This drug combination did not have any cytotoxicity in normal cells. The 283 induction of apoptosis in HCT15 cells by UA (with or without 5-FU) was shown to be 284 dependent on JNK pathway and independent of caspases. In the conditions used, the 285 apoptosis induced by UA is small and did not account for the total cell death (about 286 50%) observed, suggesting that other mechanisms must be involved. 287
Reactive oxygen species (ROS) have been shown to be involved in the 288 regulation of cell death and signalling through JNK pathway [30] . This pathway is 289 implicated in many cellular events related to cell death, such as apoptosis [15, 16] and 290 autophagy [17] [18] [19] [20] [21] [22] . Our results showed that the antioxidant NAC partially inhibited 291 apoptosis induced by UA, suggesting the involvement of ROS on UA´s effects. In 292 addition, UA activated JNK pathway, as shown by the increased levels of phospho-293 JNK. Its inhibition with SP significantly decreased UA-induced cell death and the 294 increase of the autophagic mediators LC3 and p62. Therefore, both apoptosis and total 295 14 cell death induced by UA alone or UA in combination with 5-FU were shown to involve 296 JNK pathway, possibly in response to oxidative stress produced by UA. The importance 297 of JNK activation as one contributing mechanism to cell death induction in CRC has 298 previously been demonstrated for atorvastatin. This drug was shown to induce apoptosis 299 involving JNK activation and to synergistically interact with celecoxib, a selective 300 cyclooxygenase-2 inhibitor, in killing human CRC cells [31] . Also, UA has been shown 301 to induce JNK pathway in other cell lines [32] [33] [34] [35] [36] [37] leading to cell death, however its 302 association with autophagy has never been reported. 303
Autophagy is activated under stress conditions, such as nutrient and/or growth 304 factor deprivation and, although it represents a mechanism of survival, it may assume a 305 cell death function in cancer cells when apoptosis is deregulated [11, 12] . Several 306 signalling proteins have been demonstrated to interfere with autophagy [13, 38] . In our 307 previous work, UA showed to decrease PI3K/Akt pathway [26] . Here, we observed that 308 UA also decreased the levels of phospho-mTOR, as well as, the levels of mutant p53. 309
Since an inhibition of mTOR is associated with an induction of autophagy [38, 39] and 310 the cytosolic mutant p53 has shown to inhibit autophagy [40, 41] , our results suggest 311 that UA may induce autophagy by inhibiting the PI3K/Akt/mTOR signaling and 312 decreasing mutant p53. 313
On the other hand, the ability of UA to increase the levels of autophagic 314 mediators LC3 and p62 suggest that UA may be inhibiting autophagy. LC3-II is 315 associated with autophagosome membrane reflecting its abundance. Its increasing levels 316 have been interpreted as either the result of induction or inhibition of the autophagic 317 process [42] . However, the accumulation of both LC3-I and LC3-II after long periods of 318 incubation, as observed here, is taken as an indication of inhibition of autophagy [42] . 319
In the case of p62 that is selectively incorporated into autophagosomes through binding 320 15 to LC3, its levels reflect its degradation by autophagy [42] . Therefore, an accumulation 321 of p62 represents an inhibition at later steps of the autophagic process. As a result, in 322 HCT15 cells, modulation of autophagy by UA seems to involve a dual effect: it may 323 facilitate initial stages but it inhibits autophagy at later steps. Nevertheless, UA seems to 324 be able to modulate autophagy independently of p53 status and of apoptosis cell 325 resistance, since UA had the same effects in other CRC cells, such as CO115 cell line. 326
Further experiments have to be performed to elucidate in detail the effects of UA on 327 autophagy and its implication on induction of cell death. 328
Since UA alone was more efficient in inducing cell death than 5-FU in vitro, the 329 in vivo potential of UA against CRC was evaluated in nude mice xenografted with 330 HCT15 cells. Interestingly, UA decreased tumor growth rate after 2 weeks of treatment, 331 without affecting body weight, and a tendency to increase the levels of p62 and 332 phospho-JNK in tumors was observed. These results suggest that the antitumor effect of 333 UA may involve the regulation of autophagy possibly by JNK signaling. The in vivo 334 potential of UA as an antitumorogenic agent has recently been suggested in other cancer 335 types [43, 44] . 336
In conclusion, this study shows that UA enhances the apoptotic effect 
